CN117295813A - 生产重组蛋白的方法 - Google Patents
生产重组蛋白的方法 Download PDFInfo
- Publication number
- CN117295813A CN117295813A CN202280034315.0A CN202280034315A CN117295813A CN 117295813 A CN117295813 A CN 117295813A CN 202280034315 A CN202280034315 A CN 202280034315A CN 117295813 A CN117295813 A CN 117295813A
- Authority
- CN
- China
- Prior art keywords
- magnesium
- liquid medium
- recombinant protein
- host cell
- bacterial host
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2106627.9 | 2021-05-10 | ||
| GB202106627 | 2021-05-10 | ||
| PCT/EP2022/062469 WO2022238321A1 (en) | 2021-05-10 | 2022-05-09 | Process for the production of recombinant proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117295813A true CN117295813A (zh) | 2023-12-26 |
Family
ID=81975362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280034315.0A Pending CN117295813A (zh) | 2021-05-10 | 2022-05-09 | 生产重组蛋白的方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240247050A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4337759A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024516892A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240005876A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117295813A (cg-RX-API-DMAC7.html) |
| AR (1) | AR125806A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022272406A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023022274A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3218911A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL308329A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023013277A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022238321A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013085531A (ja) * | 2011-10-20 | 2013-05-13 | Tosoh Corp | 遺伝子組換え大腸菌によるタンパク質の製造方法 |
| GB201411320D0 (en) | 2014-06-25 | 2014-08-06 | Ucb Biopharma Sprl | Antibody construct |
| US9957685B2 (en) * | 2014-08-04 | 2018-05-01 | Robert T. Yackley | Method and apparatus for portable stake mounting |
| CN104928333B (zh) * | 2015-07-07 | 2017-09-22 | 江南大学 | 一种敲除glcK促进枯草芽孢杆菌合成乙酰氨基葡萄糖的方法 |
| JP2018011515A (ja) * | 2016-07-19 | 2018-01-25 | 東ソー株式会社 | 大腸菌を用いた遺伝子組換えタンパク質の製造方法 |
| WO2020118043A1 (en) * | 2018-12-07 | 2020-06-11 | Coherus Biosciences, Inc. | Methods for producing recombinant proteins |
| WO2021072182A1 (en) * | 2019-10-11 | 2021-04-15 | Coherus Biosciences, Inc. | Methods for producing ranibizumab |
-
2022
- 2022-05-09 EP EP22728434.6A patent/EP4337759A1/en active Pending
- 2022-05-09 CN CN202280034315.0A patent/CN117295813A/zh active Pending
- 2022-05-09 MX MX2023013277A patent/MX2023013277A/es unknown
- 2022-05-09 IL IL308329A patent/IL308329A/en unknown
- 2022-05-09 KR KR1020237042029A patent/KR20240005876A/ko active Pending
- 2022-05-09 BR BR112023022274A patent/BR112023022274A2/pt unknown
- 2022-05-09 AR ARP220101213A patent/AR125806A1/es unknown
- 2022-05-09 JP JP2023569665A patent/JP2024516892A/ja active Pending
- 2022-05-09 AU AU2022272406A patent/AU2022272406A1/en active Pending
- 2022-05-09 WO PCT/EP2022/062469 patent/WO2022238321A1/en not_active Ceased
- 2022-05-09 CA CA3218911A patent/CA3218911A1/en active Pending
- 2022-05-09 US US18/290,024 patent/US20240247050A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AR125806A1 (es) | 2023-08-16 |
| BR112023022274A2 (pt) | 2024-01-30 |
| EP4337759A1 (en) | 2024-03-20 |
| CA3218911A1 (en) | 2022-11-17 |
| AU2022272406A1 (en) | 2023-11-02 |
| WO2022238321A1 (en) | 2022-11-17 |
| US20240247050A1 (en) | 2024-07-25 |
| IL308329A (en) | 2024-01-01 |
| KR20240005876A (ko) | 2024-01-12 |
| JP2024516892A (ja) | 2024-04-17 |
| MX2023013277A (es) | 2023-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2201455C2 (ru) | Способ получения чужеродного протеина в клетках e.coli, плазмидный вектор и трансформированный штамм е.coli для экспрессии чужеродного протеина | |
| CN102812042B (zh) | 用于获得抗体的方法 | |
| US10358460B2 (en) | Protein manufacture | |
| KR102202476B1 (ko) | 세포 배양 배지 및 항체 생산 방법 | |
| CN101065402B (zh) | 获得抗体的方法 | |
| US12296285B2 (en) | Methods for purifying antibodies | |
| US20240247050A1 (en) | Process for the production of recombinant proteins | |
| HK40096875A (en) | Process for the production of recombinant proteins | |
| EP3510141B1 (en) | Methods for modulating production profiles of recombinant proteins | |
| AU2023359907A1 (en) | Process for the production of recombinant proteins | |
| Stargardt et al. | One-pot expression of an oligoclonal nanobody-based antivenom in growth-decoupled Escherichia coli | |
| US20070298462A1 (en) | Process for Obtaining Antibodies | |
| HK1179272B (en) | Process for obtaining antibodies | |
| EA042536B1 (ru) | Получение белка | |
| HK1240956B (en) | Protein manufacture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40096875 Country of ref document: HK |
|
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20260715 Address after: Belgium Applicant after: Youshi Bi Brand Development Co., Ltd. Country or region after: Belgium Address before: Brussels Applicant before: UCB biopharmaceutical Co.,Ltd. Country or region before: Belgium |